Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 45,907 | 14,400 | 2,417 | 69,190 | 56,654 |
| Depreciation Amortization | 168,860 | 112,584 | 56,240 | 167,132 | 110,996 |
| Income taxes - deferred | -15,585 | -3,453 | -539 | -26,814 | -16,658 |
| Accounts receivable | -5,417 | 15,509 | -170 | -4,414 | -4,520 |
| Accounts payable and accrued liabilities | 3,673 | 6,956 | 13,919 | -11,278 | -12,088 |
| Other Working Capital | -30,071 | -21,568 | -15,704 | -54,978 | -71,787 |
| Other Operating Activity | 38,908 | 3,409 | -765 | 66,142 | 57,739 |
| Operating Cash Flow | $206,275 | $127,837 | $55,398 | $204,980 | $120,336 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 45,334 | 30,769 | 17,008 | 92,602 | 76,626 |
| PPE Investments | -1,051 | -863 | -798 | -1,652 | -1,082 |
| Net Acquisitions | N/A | N/A | N/A | -267,538 | -267,538 |
| Purchase Of Investment | -87,746 | -42,501 | -25,890 | -111,171 | -84,003 |
| Investing Cash Flow | $-43,463 | $-12,595 | $-9,680 | $-287,759 | $-275,997 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 313,175 | 313,175 |
| Debt Repayment | -48,438 | -32,292 | -16,146 | -141,058 | -124,912 |
| Common Stock Issued | 4,658 | 2,366 | 2,058 | 11,073 | 10,900 |
| Common Stock Repurchased | -25,104 | -25,104 | N/A | -60,025 | -35,000 |
| Other Financing Activity | -19,540 | -18,576 | -11,148 | -183,768 | -183,489 |
| Financing Cash Flow | $-88,424 | $-73,606 | $-25,236 | $-60,603 | $-19,326 |
| Beginning Cash Position | 96,612 | 96,612 | 96,612 | 239,994 | 239,994 |
| End Cash Position | 171,000 | 138,248 | 117,094 | 96,612 | 65,007 |
| Net Cash Flow | $74,388 | $41,636 | $20,482 | $-143,382 | $-174,987 |
| Free Cash Flow | |||||
| Operating Cash Flow | 206,275 | 127,837 | 55,398 | 204,980 | 120,336 |
| Capital Expenditure | -1,051 | -863 | -798 | -1,652 | -1,082 |
| Free Cash Flow | 205,224 | 126,974 | 54,600 | 203,328 | 119,254 |